47 related articles for article (PubMed ID: 38561692)
1. SIMOA Diagnostics on Alzheimer's Disease and Frontotemporal Dementia.
Chatziefstathiou A; Canaslan S; Kanata E; Vekrellis K; Constantinides VC; Paraskevas GP; Kapaki E; Schmitz M; Zerr I; Xanthopoulos K; Sklaviadis T; Dafou D
Biomedicines; 2024 Jun; 12(6):. PubMed ID: 38927460
[TBL] [Abstract][Full Text] [Related]
2. Migraine biomarkers in cerebrospinal fluid: A systematic review and meta-analysis.
van Dongen RM; Zielman R; Noga M; Dekkers OM; Hankemeier T; van den Maagdenberg AM; Terwindt GM; Ferrari MD
Cephalalgia; 2017 Jan; 37(1):49-63. PubMed ID: 26888294
[TBL] [Abstract][Full Text] [Related]
3. CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
Ritchie C; Smailagic N; Noel-Storr AH; Ukoumunne O; Ladds EC; Martin S
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD010803. PubMed ID: 28328043
[TBL] [Abstract][Full Text] [Related]
4. Increased CX3CL1 in cerebrospinal fluid and ictal serum t-tau elevations in migraine: results from a cross-sectional exploratory case-control study.
Süße M; Kloetzer C; Strauß S; Ruhnau J; Overeem LH; Bendig M; Schulze J; Reuter U; Vogelgesang A; Fleischmann R
J Headache Pain; 2024 Apr; 25(1):46. PubMed ID: 38561692
[TBL] [Abstract][Full Text] [Related]
5. Evaluating the utility of serum NfL, GFAP, UCHL1 and tTAU as estimates of CSF levels and diagnostic instrument in neuroinflammation and multiple sclerosis.
Koerbel K; Maiworm M; Schaller-Paule M; Schäfer JH; Jakob J; Friedauer L; Steffen F; Bittner S; Foerch C; Yalachkov Y
Mult Scler Relat Disord; 2024 Jul; 87():105644. PubMed ID: 38701697
[TBL] [Abstract][Full Text] [Related]
6. Glial and neuroaxonal biomarkers in a multiple sclerosis (MS) cohort.
Kalatha T; Hatzifilippou E; Arnaoutoglou M; Balogiannis S; Koutsouraki E
Hell J Nucl Med; 2019; 22 Suppl 2():113-121. PubMed ID: 31802051
[TBL] [Abstract][Full Text] [Related]
7. Systematic Assessment of 10 Biomarker Candidates Focusing on α-Synuclein-Related Disorders.
Schulz I; Kruse N; Gera RG; Kremer T; Cedarbaum J; Barbour R; Zago W; Schade S; Otte B; Bartl M; Hutten SJ; Trenkwalder C; Mollenhauer B
Mov Disord; 2021 Dec; 36(12):2874-2887. PubMed ID: 34363416
[TBL] [Abstract][Full Text] [Related]
8. Serum NFL and tau, but not serum UCHL-1 and GFAP or CSF SNAP-25, NPTX2, or sTREM2, correlate with delirium in a 3-year retrospective analysis.
Piel JHA; Bargemann L; Leypoldt F; Wandinger KP; Dargvainiene J
Front Neurol; 2024; 15():1356575. PubMed ID: 38566855
[TBL] [Abstract][Full Text] [Related]
9. Serum tau protein elevation in migraine: a cross-sectional case-control study.
Overeem LH; Raffaelli B; Fleischmann R; Süße M; Vogelgesang A; Maceski AM; Papadopoulou A; Ruprecht K; Su W; Koch M; Siebert A; Arkuszewski M; Tenenbaum N; Kuhle J; Reuter U
J Headache Pain; 2023 Sep; 24(1):130. PubMed ID: 37726712
[TBL] [Abstract][Full Text] [Related]
10. Serum Biomarkers of a Pro-Neuroinflammatory State May Define the Pre-Operative Risk for Postoperative Delirium in Spine Surgery.
Ruhnau J; Müller J; Nowak S; Strack S; Sperlich D; Pohl A; Dilz J; Saar A; Veser Y; Behr F; Rehberg S; Usichenko T; Hahnenkamp K; Ehler J; Flöel A; Schroeder HWS; Müller JU; Fleischmann R; Vogelgesang A
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373482
[TBL] [Abstract][Full Text] [Related]
11. A unified classification approach rating clinical utility of protein biomarkers across neurologic diseases.
Bernhardt AM; Tiedt S; Teupser D; Dichgans M; Meyer B; Gempt J; Kuhn PH; Simons M; Palleis C; Weidinger E; Nübling G; Holdt L; Hönikl L; Gasperi C; Giesbertz P; Müller SA; Breimann S; Lichtenthaler SF; Kuster B; Mann M; Imhof A; Barth T; Hauck SM; Zetterberg H; Otto M; Weichert W; Hemmer B; Levin J
EBioMedicine; 2023 Mar; 89():104456. PubMed ID: 36745974
[TBL] [Abstract][Full Text] [Related]
12. Migraine as an inflammatory disorder with microglial activation as a prime candidate.
Sudershan A; Younis M; Sudershan S; Kumar P
Neurol Res; 2023 Mar; 45(3):200-215. PubMed ID: 36197286
[TBL] [Abstract][Full Text] [Related]
13. Biological correlates of elevated soluble TREM2 in cerebrospinal fluid.
Winfree RL; Dumitrescu L; Blennow K; Zetterberg H; Gifford KA; Pechman KR; Jefferson AL; Hohman TJ;
Neurobiol Aging; 2022 Oct; 118():88-98. PubMed ID: 35908327
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
